18Mar 2023
Taurodeoxycholic acid-YAP1 upregulates OTX1 in promoting gallbladder cancer malignancy through IFITM3-dependent AKT activation

Taurodeoxycholic acid-YAP1 upregulates OTX1 in promoting gallbladder cancer malignancy through IFITM3-dependent AKT activation

The study reports that the overexpression of Orthodenticle homeobox (OTX1) is associated with poor prognosis in gallbladder cancer (GBC). In vitro and in vivo studies demonstrate that OTX1 promotes cell proliferation and its downregulation inhibits it. The study also found a correlation between the serum level of taurodeoxycholic acid (TDCA) and OTX1 expression. TDCA-induced activation of YAP1 by phosphorylation inhibition contributed to the transcriptional activation of OTX1. Mechanistically, the study identified that OTX1 activates the AKT signaling pathway by transactivating the expression of IFITM3, thus promoting GBC cell proliferation. The study suggests that OTX1 could be a novel therapeutic target for GBC.

  • #oncology

Like

Save

Share